Lewis Lung Carcinoma (LLC, from ATCC, Teddington, UK) cells were grown in DMEM (Dulbecco's Modified Eagle Medium (Invitrogen, Paisley, UK); 4.5 g L −1 glucose, L-glutamine, pyruvate) supplemented with 10% FBS (fetal bovine serum, PAA laboratories, Yeovil, UK) and maintained in a 5% CO 2 , water-saturated atmosphere at 37 • C.
Cell surface azidoglycan labeling and quantitation with fluorescence microscopy imaging
LLC cells were seeded onto 4-well coverslip chambers (Lab-Tek TM borosylicate, Nunc, Roskilde, Denmark)
at 2×10 −4 /cm 2 and allowed to adhere to the plate surface for 6 h. After adhesion, cells were pulsed with either (+) Ac 4 GalNAz (50 µM) or vehicle (-) for 24 hours. Cells were then washed 3 times in ice cold FACS buffer before being incubated (15 min, 37 • C) in situ in 200 µL of FACS buffer containing 5 µM TMDIBOAlexa Fluor 647, DIFO3-Alexa Fluor 647 or PHOS-Alexa Fluor 647 and 300 nM DAPI, Invitrogen). After being washed as above, cells were fixed in PBS containing 4% formaline (RT, 15 min, 37 • C) and washed again twice in cold PBS. The chambers were scanned on an iCys Research Imaging Cytometer (CompuCyte, Westwood, MA, U.S.A.) using 405 nm and 633 nm lasers. A 60x objective was used with 0.5 µm X-step size, giving a field size of 500 µm x 132 µm. A total of 300 fields were scanned for each chamber well. Watershed filters were also included in the protocol to ensure separate contouring on closely spaced cells. Images were analysed using primary and peripheral contours to sample cytoplasmic and membrane staining per cell respectively. The primary contour was set on the blue (DAPI) channel with an integration contour of 8 pixels to include cytoplasmic staining. The peripheral contour was set to a width of 8 pixels measuring from the outer edge of the integration contour. A sub contour was set with a threshold on the long red channel to measure total Alexa Fluor 647 staining per cell.
MSA-binding assay
Mouse serum albumin (Sigma-Aldrich; 10 g/l, 145.6 µM) was incubated with TMDIBO-Alexa Fluor 647, DIFO3-Alexa Fluor 647 or PHOS-Alexa Fluor 647 (4 µM) for 1 h at 37 • C (HBS buffer, 20 mM HEPES, 150 mM NaCl, pH 7.4). After the reaction the samples were cooled to 4 • C, diluted in native gel loading buffer (Expedeon, Harston, UK) and loaded onto native gels (10% acrylamide, Expedeon). Samples of MSA, prereacted with iodoacetamide (80-fold molar excess, HBS buffer, 37 • C, 1 h) were incubated with the different probes at similar molar excess, and loaded onto the same gel for comparison. Any unbound fluorophore eluted off the end of the gel during the electrophoresis. Gels were imaged for fluorescence (excitation, λ: 630 nm; emission, λ: 680 nm) on a Typhoon TM Trio scanner (GE Healthcare, Little Chalfont, UK); later stained with Instant Blue TM gel stain (Expedeon) and re-imaged on a bright-field scanner (ImageScanner III TM ; GE Healthcare). Densitometry analysis of fluorescence-imaged gels was performed using ImageJ TM software (National Institutes of Health, Bethesda, MD, USA). 100 µg of MSA were loaded per gel lane. Native gel sample loading buffer showed some autofluorescence at 647 nm (lanes 1 and 2 in Figure S2A ), which was used to standardize the total lane fluorescence in Figure S2A (result shown in Figure S2C ). Figure S3 and S4). 
General methods and materials
NMR spectra were recorded on the following instruments: Bruker DRX500, Bruker Avance BB, Bruker Avance TCI, Bruker AM400 and Bruker DRX400. All chemical shifts are quoted in ppm, relative to tetramethylsilane, using the residual solvent peak as a reference standard. All coupling constants are quoted in Hz. Infrared spectra were recorded on a Perkin Elmer Spectrum One (FT-IR) spectrophotometer. High resolution mass spectra (HRMS) were recorded on a Waters LCT Premier TOF mass spectrometer with electrospray and modular Lockspray interface. Analytical thin layer chromatography (TLC) was carried out on Merck Kieselgel 60 F254 plates with visualisation by ultra violet light (254 nm), potassium permanganate and/or phosphomolybdic acid /Ce(SO 4 ) 2 dip. Flash column chromatography was carried out using Merck Kieselgel 60 (230-400 mesh). HPLC was carried out on a Varian ProStar system, UV detection at 254 nm, Phenomenex Jupiter C18 column, particle size 5 µm. LC-MS analysis was performed on a Waters 2795 system, UV detection at 254 nm, Supelco ABZ+plus column, 3.3cm x 4.6mm, particle size 3 µm. All solvent mixtures are reported as % vol/vol unless otherwise stated. Reagents and solvents were purified using standard means. All other chemicals were used as received unless noted otherwise. Extractive procedures were performed using distilled solvents and evaporation of solvents was performed under reduced pressure. All aqueous solutions used were saturated. Unless otherwise stated, all non-aqueous reactions were carried out under an argon atmosphere using anhydrous conditions and oven-dried glassware. Standard techniques were employed for handling air-sensitive materials.
cLogP values were calculated using ChemBioOffice 12.0 as follows: DIFO3 9 2.7; TMDIBO 8 3.2; DIBO 5 3.9; the amide of PHOS 1 (R = H) 4.5.
Synthetic procedures
2,2-Difluoro-3-hydroxycyclooctanone 25 (Z)-3-(Benzyloxy)-2,2-difluorocyclooct-4-enone [1] 24 (2.5 g, 9.39 mmol) was dissolved in EtOH (188 ml). The reaction flask was purged with Argon and Pd/C (1.7 g, 1.597 mmol) was added. The reaction flask was pump-purged with hydrogen, and the reaction was stirred under hydrogen at room temperature for 30 min. 
2,2-Difluorocyclooct-3-ynol (DIFO3) 9
Enol triflate 27 (1.9 g, 4.48 mmol) was dissolved in THF (90 ml) and the mixture was cooled to -20 • C with stirring. Freshly prepared LDA (0.5 M in THF; 11.64 ml, 5.82 mmol) was added dropwise at the same temperature. The reaction mixture was allowed to warm to r. 
2,2-Difluorocyclooct-3-yn-1-yl (4-nitrophenyl) carbonate 33
2,2-Difluorocyclooct-3-ynol 9 (0.1 g, 0.624 mmol) was dissolved in CH 2 Cl 2 (12.49 ml) with stirring at r.t., and then pyridine (0.252 ml, 3.12 mmol) and 4-nitrophenyl chloroformate (0.126 g, 0.624 mmol) were added at r.t. The reaction was followed by TLC and when the starting material had disappeared (ca. 1 h), the mixture was diluted with CH 2 Cl 2 and washed with brine (2x 3-tert-Butyldimethylsilyloxy-2',3',2",3"-tetramethoxy-1,2:5,6-dibenzocyclocta-1,5,7-triene 14 tert-Butyldimethylsilyl chloride (12.65 ml, 73.0 mmol) was added to a stirred solution of 3-hydroxy-2',3',2",3"-tetramethoxy-1,2:5,6-dibenzocyclocta-1,5,7-triene [2] 
Stability tests
TMDIBO (50 mg, 0.147 mmol) was dissolved in MeCN (0.7 mL), then H 2 O (0.7 mL) and K 2 CO 3 (60.9 mg, 0.441 mmol, 3.0 eq.) were added. The mixture was heated to 110 • C for 4 h. The solvent was removed in vacuo and the residue extracted with EtOAc (3x). The organic phases were dried over MgSO 4 , the solvent removed in vacuo. TMDIBO was isolated as a white solid (50 mg, 100%). The 1 H-NMR spectrum was identical to that reported above. TMDIBO (50 mg, 0.147 mmol) was dissolved in a mixture of MeOH, THF and HCl (3 M) (1:1:1, 1.0 mL). The mixture was heated to 70 • C with stirring, the reaction being monitored by LC-MS. After 12 h (ca. 50% conversion), the solvent was removed in vacuo, the residue taken up in H 2 O and extracted with EtOAc (3x). The organic phases were dried over MgSO 4 . The solvent was removed in vacuo and the product purified by flash chromatography (gradient elution 30%-60% EtOAc/hexane). The product was isolated as a white solid (24.5 mg, 49%). The 1 H-NMR spectrum was identical to that reported above. -10  0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190  200  210  220  230  240 f1 ( 1H NMR 400.14 MHz CDCl3 
13C NMR
100.61 MHz CDCl3 -4.65 -4.55 18.36 25.78 25.99 46.91 55.83 55.92 71.65 76.84 77.16 77.48 109.02 110.90 113.18 113.45 126.78 128.23 128.82 129.20 132.58 136.26 146.65 147.19 147.84 148.36 Supplementary0.00 2.53 2.54 2.54 2.55 2.55 2.62 2.63 2.65 2.66 3.04 3.05 3.08 3.08 3.35 3.81 3.81 3.86 5.78 5.79 6.96 6.96 7.13 7.37 Supplementary
100.61 MHz DMSO 39.28 39.49 39.70 39.91 40.12 40.33 40.54 49.50 55.84 56.02 56.14 74.47 109.48 109.52 110.46 112.20 112.37 114.71 115.19 145.69 147.42 147.72 148.82 149.11 150.98 Supplementary1.56 2.89 2.89 2.91 2.92 2.95 2.96 2.98 2.99 3.21 3.22 3.24 3.70 3.72 3.72 3.74 3.88 3.89 3.90 3.91 3.93 3.94 3.95 5.50 5.51 5.51 5.51 5.51 5.52 6.13 6.13 6.15 6.15 6.83 6.84 6.86 6.86 6.88 6.88 6.90 6.90 7.13 7.26 7.41 7.42 7.43 8.13 8.15 8.27 8.27 8.28 8.29 8.29 Supplementary
13C NMR 125.74 MHz CDCl3
39.33 46.16 56.07 56.08 56.11 56.13 78.48 82.13 107.68 108.16 108.74 108.78 109.16 109.27 109.52 110.36 112.72 113.16 113.85 115.33 115.55 115.56 115.61 118.18 121.53 121.79 125.06 125.33 139.35 140.27 143.03 143.52 145.32 145.38 148.05 148.14 148.20 148.92 149.18 149.63 151.54 152.11 155.27 155.43 Supplementary1.23 1.24 1.25 1.26 1.27 1.57 1.58 1.58 1.60 1.61 1.61 1.62 1.62 1.63 1.63 1.73 1.75 1.76 1.77 1.77 1.78 1.79 1.80 1.80 1.82 1.87 1.88 1.88 1.89 1.89 1.90 1.90 1.91 1.92 1.92 1.93 1.93 1.93 1.94 1.94 1.94 1.95 1.95 1.96 2.05 2.05 2.05 2.05 2.06 2.06 2.48 2.54 2.54 2.55 2.55 2.56 2.57 2.57 2.57 2.58 2.58 2.58 2.59 2.60 2.60 2.61 2.61 2.68 2.69 2.70 2.71 2.71 2.72 2.73 2.75 Supplementary
13C NMR 125.75 MHz CDCl3
19.32 22.99 27.08 27.10 27.11 27.13 27.34 39.63 52.66 73.05 73.23 73.25 73.43 77.00 115.29 117.29 117.34 119.34 204.08 204.28 204.31 204.0.07 0.11 0.89 1.76 1.77 1.77 1.79 1.80 1.81 1.92 1.93 1.94 1.95 2.00 2.01 2.02 2.55 2.55 2.55 2.56 2.56 2.57 2.58 2.58 2.67 2.68 2.69 2.70 3.91 3.93 3.94 3.95 3.96 3.97 3.98 4.00 7.26 Supplementary
MHz CDCl3
-5.22 -4.99 11.42 14.04 14.10 14.30 18.11 18.74 19.21 20.43 22.32 22.60 23.03 25.59 27.38 27.65 28.77 28.80 28.83 29.04 34.11 36.06 39.60 41.33 73.47 73.64 73.68 73.85 115.12 117.12 117.18 119.18 203.93 204.13 204.16 204.36 Supplementary0.08 0.10 0.89 1.66 1.67 1.68 1.69 1.70 1.71 1.85 1.86 1.89 2.20 2.21 2.22 2.23 2.24 2.24 2.26 2.50 2.51 2.52 2.53 2.54 2.55 2.56 4.13 4.14 4.15 4.16 4.17 4.18 4.19 4.19 6.01 6.02 6.02 6.03 6.04 6.04 6.05 6.05 6.06 6.06 6.07 6.07 6.08 7.26 Supplementary1.40 1.42 1.43 1.44 1.45 1.73 1.73 1.74 1.75 1.76 1.76 1.77 1.78 1.78 1.80 1.80 1.93 1.93 1.94 1.94 1.94 1.95 1.95 1.96 1.96 1.97 1.97 1.98 1.99 1.99 2.00 2.00 2.01 2.01 2.01 2.02 2.02 2.03 2.03 2.04 2.05 2.05 2.14 2.15 2.16 2.17 2.18 2.19 2.19 2.27 2.27 2.27 2.28 2.28 2.29 2.32 2.33 2.33 2.33 2.35 2.35 2.35 2.36 2.36 2.37 4.02 4.03 4.03 4.04 4.04 4.04 4.05 4.05 4.06 4.06 4.07 4.
19F NMR 376.50 MHz CDCl3
1.00 1.00 20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190 f1 ( ---------------------------------------------------------------- ******************************************************************************* ******************************************************************************* ******************************************************************************* 
13C NMR
100.61 MHz CDCl3 20.33 24.73 30.49 32.65 81.69 82.10 82.14 82.55 84.21 84.44 84.50 84.72 111.73 111.85 111.96 113.14 115.53 115.57 117.96 121.85 125.48 145.70 151.86 155.47 Supplementary-108.63 -108.61 -108.59 -108.57 -108.55 -107.94 -107.92 -107.90 -107.88 -107.86 -101.90 -101.21 Supplementary Material (ESI) for Chemical Science This journal is (c) The Royal Society of Chemistry 2011 Print Date: Sat May 01 09:54:27 2010 Page 1 of 1 Title : Run File : C:\Star\data\Henning\difo647.run Method File3 ----------------========== -------======= ========== ------------------------------------------------------------------------------- 1----------------========== -------======= ========== ------------------------------------------------------------------------------- 1 100.0000 16.806 0.000 22861 PB 7.6 ----------------========== -------======= ========== --------------
